A new market research report from Kalorama Information, "Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends," says that diagnostics and treatment segments taken together are valued at more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion.
The market has grown by 3 percent year-on-year, with sales increasing from $7.9 billion in 2005. With the treatment segment struggling to maintain growth, the testing segment is likely to offset declines starting in 2012.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.